Myositis-Specific 11 Antibody Panel

Myositis-specific autoantibodies are highly selective markers that map to distinct subtypes within the inflammatory myopathy spectrum, including polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis. This panel measures 11 of them: the anti-synthetase group (Jo-1, PL-7, PL-12, EJ, OJ) tied to muscle inflammation plus interstitial lung disease, anti-SRP linked to severe necrotizing myopathy, anti-Mi-2 (alpha and beta) seen in classic dermatomyositis skin and muscle features, anti-MDA5 associated with skin-predominant disease and rapidly progressive lung involvement, and anti-TIF1-gamma and anti-NXP-2 which define further dermatomyositis subsets. It is ordered when symptoms point toward myositis: proximal muscle weakness, difficulty climbing stairs or lifting overhead, the rashes of dermatomyositis, unexplained interstitial lung disease, or elevated muscle enzymes like CK. These antibodies are usually mutually exclusive, so a positive result not only supports the diagnosis but predicts the likely organ involvement, with anti-TIF1-gamma in adults flagging the need for cancer screening and anti-MDA5 prompting close attention to the lungs.